New study aims to end guesswork in atrial fibrillation treatment
NCT ID NCT05084495
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study followed 50 atrial fibrillation patients for 12 months to see if advanced heart imaging and ECG tests can predict whether the drug flecainide will keep their heart in normal rhythm. Researchers collected data during four clinic visits and analyzed it against outcomes like side effects and rhythm control. The goal is to move away from trial-and-error prescribing and give the right treatment to the right patient from the start.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could help doctors predict which atrial fibrillation patients will benefit from flecainide, reducing side effects and improving treatment success.
What could go wrong
This is a small observational study, not a treatment trial. The findings may not apply to all patients and need confirmation in larger studies.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Sciences, Helsingborg Medical Faculty Lund University
Helsingborg, Skåne County, 25187, Sweden